Dr. Agarwal's Health Care Limited Share Price & Analysis
₹485.8▲ +0.23%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹485.8
+0.23%
Open
₹—
High
₹491.45
Low
₹482.55
Close
₹485.8
52W High
₹568
52W Low
₹401
Volume
62K
Lot Size
1
Sector
Healthcare
Market Cap
₹15K Cr
Face Value
₹1
Mid Cap
Price Chart
Fundamentals
P/E
116
Sector P/E
54.4
P/B
7.47
EPS
₹4.19
ROE
6.81%
ROCE
11.1%
D/E Ratio
0.5
Div Yield
0%
Book Value
₹63.9
−
Concerns
- ✗Premium to sector peers (P/E 116x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AGARWALEYE · as of Jun 2026
Promoters32.34%
FII57.97%▲0.03
DII7.72%▼0.11
Public1.97%▲0.10
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 32.45% | 32.43% | 32.43% | 32.39% | 32.35% | 32.34% |
| FII | 60.62% | 59.26% | 58.13% | 58.06% | 57.94% | 57.97% |
| DII | 5.21% | 6.44% | 7.92% | 7.78% | 7.83% | 7.72% |
| Public | 1.74% | 1.87% | 1.52% | 1.78% | 1.87% | 1.97% |
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹564 Cr ▲6.4% | ₹530 Cr ▲6.2% | ₹499 Cr ▲2.5% | ₹487 Cr ▲5.9% | ₹460 Cr ▲6.7% | ₹431 Cr ▲3.4% | ₹417 Cr ▲3.5% | ₹403 Cr |
| Op. Profit | ₹161 Cr ▲11.8% | ₹144 Cr ▲5.9% | ₹136 Cr ▲6.3% | ₹128 Cr ▼2.3% | ₹131 Cr ▲13.9% | ₹115 Cr ▲7.5% | ₹107 Cr ▲2.9% | ₹104 Cr |
| OPM | 29.0% ▲7.4% | 27.0% ▲0.0% | 27.0% ▲3.8% | 26.0% ▼7.1% | 28.0% ▲3.7% | 27.0% ▲3.8% | 26.0% ▲0.0% | 26.0% |
| Net Profit | ₹50 Cr ▲13.6% | ₹44 Cr ▲22.2% | ₹36 Cr ▼5.3% | ₹38 Cr ▼11.6% | ₹43 Cr ▲53.6% | ₹28 Cr ▲33.3% | ₹21 Cr ▲16.7% | ₹18 Cr |
| EPS (₹) | 1.25 ▲16.8% | 1.07 ▲13.8% | 0.94 ▼1.1% | 0.95 ▼7.8% | 1.03 ▲43.1% | 0.72 | — | — |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹2.1K Cr ▲21.6% | ₹1.7K Cr ▲28.5% | ₹1.3K Cr ▲30.8% | ₹1.0K Cr ▲46.3% | ₹696 Cr ▲47.8% | ₹471 Cr ▼11.3% | ₹531 Cr |
| Expenses | ₹1.5K Cr ▲21.1% | ₹1.2K Cr ▲29.3% | ₹965 Cr ▲29.9% | ₹743 Cr ▲45.7% | ₹510 Cr ▲31.8% | ₹387 Cr ▼4.9% | ₹407 Cr |
| Op. Profit | ₹570 Cr ▲23.1% | ₹463 Cr ▲26.2% | ₹367 Cr ▲33.5% | ₹275 Cr ▲47.8% | ₹186 Cr ▲118.8% | ₹85 Cr ▼31.5% | ₹124 Cr |
| OPM | 27.0% ▲0.0% | 27.0% ▼3.6% | 28.0% ▲3.7% | 27.0% ▲0.0% | 27.0% ▲50.0% | 18.0% ▼21.7% | 23.0% |
| Other Income | ₹46 Cr ▲7.0% | ₹43 Cr ▼2.3% | ₹44 Cr ▲214.3% | ₹14 Cr ▼17.6% | ₹17 Cr ▲183.3% | ₹6 Cr ▼53.8% | ₹13 Cr |
| Interest | ₹90 Cr ▼21.7% | ₹115 Cr ▲13.9% | ₹101 Cr ▲32.9% | ₹76 Cr ▲55.1% | ₹49 Cr ▲11.4% | ₹44 Cr ▼18.5% | ₹54 Cr |
| Depreciation | ₹276 Cr ▲19.5% | ₹231 Cr ▲35.9% | ₹170 Cr ▲32.8% | ₹128 Cr ▲30.6% | ₹98 Cr ▲3.2% | ₹95 Cr ▲2.2% | ₹93 Cr |
| PBT | ₹249 Cr ▲55.6% | ₹160 Cr ▲13.5% | ₹141 Cr ▲67.9% | ₹84 Cr ▲47.4% | ₹57 Cr ▲218.8% | ₹-48 Cr ▼336.4% | ₹-11 Cr |
| Tax % | 32.0% ▲3.2% | 31.0% ▼3.1% | 32.0% ▲233.3% | -24.0% ▼200.0% | 24.0% ▲14.3% | 21.0% ▼74.4% | 82.0% |
| Net Profit | ₹168 Cr ▲52.7% | ₹110 Cr ▲15.8% | ₹95 Cr ▼7.8% | ₹103 Cr ▲139.5% | ₹43 Cr ▲172.9% | ₹-59 Cr ▼181.0% | ₹-21 Cr |
| EPS (₹) | 4.2 ▲59.1% | 2.64 | — | — | — | — | — |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Liabilities | |||||||
| Equity Capital | ₹32 Cr ▲0.0% | ₹32 Cr ▲255.6% | ₹9 Cr ▲12.5% | ₹8 Cr ▲14.3% | ₹7 Cr ▲0.0% | ₹7 Cr ▲0.0% | ₹7 Cr |
| Reserves | ₹2.0K Cr ▲8.7% | ₹1.8K Cr ▲38.0% | ₹1.3K Cr ▲113.8% | ₹622 Cr ▲201.9% | ₹206 Cr ▲16.4% | ₹177 Cr ▼26.9% | ₹242 Cr |
| Borrowings | ₹1.1K Cr ▲10.9% | ₹961 Cr ▼0.5% | ₹966 Cr ▲12.7% | ₹857 Cr ▲35.4% | ₹633 Cr ▲242.2% | ₹185 Cr ▲14.2% | ₹162 Cr |
| Other Liabilities | ₹850 Cr ▲1.6% | ₹837 Cr ▲88.1% | ₹445 Cr ▲32.4% | ₹336 Cr ▲87.7% | ₹179 Cr ▼57.1% | ₹417 Cr ▲23.0% | ₹339 Cr |
| Total Liabilities | ₹3.9K Cr ▲7.6% | ₹3.7K Cr ▲33.2% | ₹2.8K Cr ▲50.9% | ₹1.8K Cr ▲77.9% | ₹1.0K Cr ▲30.2% | ₹787 Cr ▲4.8% | ₹751 Cr |
| Assets | |||||||
| Fixed Assets | ₹2.9K Cr ▲14.1% | ₹2.5K Cr ▲44.5% | ₹1.7K Cr ▲35.0% | ₹1.3K Cr ▲84.5% | ₹701 Cr ▲21.9% | ₹575 Cr ▲4.4% | ₹551 Cr |
| CWIP | ₹234 Cr ▲52.9% | ₹153 Cr ▲29.7% | ₹118 Cr ▲19.2% | ₹99 Cr ▲253.6% | ₹28 Cr ▲154.5% | ₹11 Cr ▲37.5% | ₹8 Cr |
| Investments | ₹152 Cr ▼42.4% | ₹264 Cr ▼43.9% | ₹471 Cr ▲1285.3% | ₹34 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹1 Cr |
| Other Assets | ₹676 Cr ▼6.6% | ₹724 Cr ▲74.0% | ₹416 Cr ▲4.8% | ₹397 Cr ▲34.6% | ₹295 Cr ▲46.8% | ₹201 Cr ▲4.7% | ₹192 Cr |
| Total Assets | ₹3.9K Cr ▲7.6% | ₹3.7K Cr ▲33.2% | ₹2.8K Cr ▲50.9% | ₹1.8K Cr ▲77.9% | ₹1.0K Cr ▲30.2% | ₹787 Cr ▲4.8% | ₹751 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹519 Cr ▲44.2% | ₹360 Cr ▲4.0% | ₹346 Cr ▲48.5% | ₹233 Cr ▲42.1% | ₹164 Cr ▲65.7% | ₹99 Cr ▼3.9% | ₹103 Cr |
| Investing CF | ₹-308 Cr ▲58.9% | ₹-750 Cr ▲17.9% | ₹-914 Cr ▼79.6% | ₹-509 Cr ▼228.4% | ₹-155 Cr ▼237.0% | ₹-46 Cr ▲45.9% | ₹-85 Cr |
| Financing CF | ₹-220 Cr ▼157.6% | ₹382 Cr ▼30.9% | ₹553 Cr ▲82.5% | ₹303 Cr ▲765.7% | ₹35 Cr ▲194.6% | ₹-37 Cr ▲49.3% | ₹-73 Cr |
| Net Cash Flow | ₹-10 Cr ▼25.0% | ₹-8 Cr ▲46.7% | ₹-15 Cr ▼155.6% | ₹27 Cr ▼38.6% | ₹44 Cr ▲158.8% | ₹17 Cr ▲130.4% | ₹-56 Cr |
| Free Cash Flow | ₹59 Cr ▲47.5% | ₹40 Cr ▼66.1% | ₹118 Cr ▲55.3% | ₹76 Cr ▼20.0% | ₹95 Cr ▲43.9% | ₹66 Cr ▲167.3% | ₹-98 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 28d ▲7.7% | 26d ▼3.7% | 27d ▲0.0% | 27d ▼10.0% | 30d ▼16.7% | 36d ▲0.0% | 36d |
| Inventory Days | 178d ▼1.7% | 181d ▲31.2% | 138d ▲19.0% | 116d ▼19.4% | 144d ▼14.8% | 169d ▼5.1% | 178d |
| Days Payable | 283d ▼18.0% | 345d ▼2.8% | 355d ▲8.9% | 326d ▼16.2% | 389d ▼13.9% | 452d ▲32.9% | 340d |
| Cash Conv. Cycle | -76d ▲44.9% | -138d ▲27.4% | -190d ▼3.8% | -183d ▲14.9% | -215d ▲13.0% | -247d ▼96.0% | -126d |
| Working Capital Days | -3d ▲93.2% | -44d ▲32.3% | -65d ▼4.8% | -62d ▼24.0% | -50d ▼6.4% | -47d ▼51.6% | -31d |
| ROCE | 11.0% ▲10.0% | 10.0% ▼9.1% | 11.0% ▼15.4% | 13.0% ▼23.5% | 17.0% ▲1800.0% | -1.0% | — |
Source: Screener.in · Lower days = better efficiency
About Dr. Agarwal's Health Care Limited
Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Dr. Agarwal's Health Care Limited share price today?▾
Dr. Agarwal's Health Care Limited (AGARWALEYE) is currently trading at ₹485.8 on NSE, up 0.23% as of the last market session. Prices update daily after market close on MarketNetra.
Is Dr. Agarwal's Health Care Limited available in F&O (Futures & Options)?▾
Yes, Dr. Agarwal's Health Care Limited (AGARWALEYE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Dr. Agarwal's Health Care Limited 52-week high and low?▾
Dr. Agarwal's Health Care Limited's 52-week high is ₹568 and the 52-week low is ₹401. The current price of ₹485.8 is 14.5% below the 52W high.
What is Dr. Agarwal's Health Care Limited P/E ratio?▾
Dr. Agarwal's Health Care Limited's current P/E ratio is 116. This indicates the market is paying ₹116 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Dr. Agarwal's Health Care Limited options?▾
Dr. Agarwal's Health Care Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AGARWALEYE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.